<DOC>
	<DOCNO>NCT00854425</DOCNO>
	<brief_summary>The purpose study evaluate efficacy tolerability L-asparaginase monotherapy salvage treatment patient NK/T cell lymphoma</brief_summary>
	<brief_title>L-asparaginase Monotherapy Salvage Treatment Patients With NK/T Cell Lymphoma</brief_title>
	<detailed_description>The prognosis patient progressive recurrent NK/T cell lymphoma poor partially due lack effective treatment . L-asparaginase report effective set several case report . The investigator aim evaluate efficacy toxicity L-asparaginase monotherapy prospective phase II study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>Age range 1875 year old Histological confirm NK/T cell lymphoma progressive recurrent disease ECOG performance status 02 Life expectancy 3 month Normal laboratory value : hemoglobin &gt; 80 g/dl , neutrophil &gt; 2×109/L , platelet &gt; 100×109/L , serum creatine &lt; 1.5×upper limitation normal ( ULN ) , serum bilirubin &lt; 1.5×ULN , ALT AST &lt; 2.5×ULN Pregnant lactate woman Serious uncontrolled disease intercurrent infection The evidence CNS metastasis History malignancy except cure basal cell carcinoma skin carcinoma insitu uterine cervix</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>